Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Simone Krebs

Showing results (31-40 of 59) with videos related to

Pageof 6
Sort By:
Molecular Imaging and Biology|September 19, 2025
Today's Research, Tomorrow's Practice - White Paper from the Translation of New Therapy (TNT) Radiotheranostics Kick-off Pre-meeting of the Annual World Molecular Imaging Conference 2024Simone Krebs, Lisa Baird, Giacomo Pirovano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2015
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive GliomaGiedre Krenciute, Simone Krebs, David Torres, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumorsSimone Krebs, Neeta Pandit-Taskar, Diane Reidy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2023
Dosimetric variability across a library of computational tumor phantomsLukas M Carter, Simone Krebs, Harry Marquis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment ManagementSimone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2014
Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot studyDamian Wild, Melpomeni Fani, Richard Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered LymphocytesSimone Krebs, Afruja Ahad, Lukas M Carter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Pageof 6

Showing results (31-40 of 59) with videos related to

Sort By:
Pageof 6
Molecular Imaging and Biology|September 19, 2025
Today's Research, Tomorrow's Practice - White Paper from the Translation of New Therapy (TNT) Radiotheranostics Kick-off Pre-meeting of the Annual World Molecular Imaging Conference 2024Simone Krebs, Lisa Baird, Giacomo Pirovano, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 31, 2015
Characterization and Functional Analysis of scFv-based Chimeric Antigen Receptors to Redirect T Cells to IL13Rα2-positive GliomaGiedre Krenciute, Simone Krebs, David Torres, et al.
European Journal of Nuclear Medicine and Molecular Imaging|October 31, 2018
Biodistribution and radiation dose estimates for <sup>68</sup>Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumorsSimone Krebs, Neeta Pandit-Taskar, Diane Reidy, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 8, 2020
Comparison of <sup>68</sup>Ga-DOTA-JR11 PET/CT with dosimetric <sup>177</sup>Lu-satoreotide tetraxetan (<sup>177</sup>Lu-DOTA-JR11) SPECT/CT in patients with metastatic neuroendocrine tumors undergoing peptide receptor radionuclide therapySimone Krebs, Joseph A O'Donoghue, Evan Biegel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 19, 2023
Dosimetric variability across a library of computational tumor phantomsLukas M Carter, Simone Krebs, Harry Marquis, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2026
Renal Medullary Carcinoma: Utility of [<sup>18</sup>F]FDG PET/CT in Evaluating Extent of Disease and Impact on Treatment ManagementSimone Krebs, Ahmed E Salem, Nghi C Nguyen, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 26, 2014
Comparison of somatostatin receptor agonist and antagonist for peptide receptor radionuclide therapy: a pilot studyDamian Wild, Melpomeni Fani, Richard Fischer, et al.
European Journal of Nuclear Medicine and Molecular Imaging|September 9, 2021
[<sup>89</sup>Zr]Zr-huJ591 immuno-PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 16, 2018
Antibody with Infinite Affinity for In Vivo Tracking of Genetically Engineered LymphocytesSimone Krebs, Afruja Ahad, Lukas M Carter, et al.
European Journal of Nuclear Medicine and Molecular Imaging|March 10, 2022
Correction to: [<sup>89</sup>Zr]Zr‑huJ591 immuno‑PET targeting PSMA in IDH mutant anaplastic oligodendrogliomaSimone Krebs, Christian Grommes, Michael R McDevitt, et al.
Pageof 6